cloudfront

Report Detail

Pharma & Healthcare Global Anticancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541302
  • |
  • 06 November, 2018
  • |
  • Global
  • |
  • 117 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Anticancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Anticancer Drug Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Targeted Drugs
  • 1.2.2 Cytotoxic Drugs
  • 1.2.3 Hormonal Drugs
  • 1.3 Market Analysis by Applications
  • 1.3.1 Immunotherapy
  • 1.3.2 Targeted Therapy
  • 1.3.3 Chemotherapy
  • 1.3.4 Hormonal Therapy
  • 1.3.5 Others
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Roche
    • 2.1.1 Business Overview
  • 2.1.2 Anticancer Drug Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Roche Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Celgene
  • 2.2.1 Business Overview
  • 2.2.2 Anticancer Drug Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Celgene Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Anticancer Drug Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Pfizer Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Bristol-Myers Squibb
  • 2.4.1 Business Overview
  • 2.4.2 Anticancer Drug Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Bristol-Myers Squibb Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Novartis
  • 2.5.1 Business Overview
  • 2.5.2 Anticancer Drug Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Novartis Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 AstraZeneca
  • 2.6.1 Business Overview
  • 2.6.2 Anticancer Drug Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 AstraZeneca Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Teva Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Anticancer Drug Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Teva Pharmaceuticals Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Bayer
  • 2.8.1 Business Overview
  • 2.8.2 Anticancer Drug Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Bayer Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 GlaxoSmithKline
  • 2.9.1 Business Overview
  • 2.9.2 Anticancer Drug Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 GlaxoSmithKline Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Anticancer Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Anticancer Drug Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Anticancer Drug Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Anticancer Drug Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Anticancer Drug Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Anticancer Drug Market Analysis by Regions

    • 4.1 Global Anticancer Drug Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Anticancer Drug Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Anticancer Drug Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Anticancer Drug Sales and Growth Rate (2013-2018)
  • 4.3 Europe Anticancer Drug Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Anticancer Drug Sales and Growth Rate (2013-2018)
  • 4.5 South America Anticancer Drug Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Anticancer Drug Sales and Growth Rate (2013-2018)
  • 5 North America Anticancer Drug by Countries

    • 5.1 North America Anticancer Drug Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Anticancer Drug Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Anticancer Drug Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Anticancer Drug Sales and Growth Rate (2013-2018)
  • 5.3 Canada Anticancer Drug Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Anticancer Drug Sales and Growth Rate (2013-2018)
  • 6 Europe Anticancer Drug by Countries

    • 6.1 Europe Anticancer Drug Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Anticancer Drug Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Anticancer Drug Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Anticancer Drug Sales and Growth Rate (2013-2018)
  • 6.3 UK Anticancer Drug Sales and Growth Rate (2013-2018)
  • 6.4 France Anticancer Drug Sales and Growth Rate (2013-2018)
  • 6.5 Russia Anticancer Drug Sales and Growth Rate (2013-2018)
  • 6.6 Italy Anticancer Drug Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Anticancer Drug by Countries

    • 7.1 Asia-Pacific Anticancer Drug Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Anticancer Drug Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Anticancer Drug Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Anticancer Drug Sales and Growth Rate (2013-2018)
  • 7.3 Japan Anticancer Drug Sales and Growth Rate (2013-2018)
  • 7.4 Korea Anticancer Drug Sales and Growth Rate (2013-2018)
  • 7.5 India Anticancer Drug Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Anticancer Drug Sales and Growth Rate (2013-2018)
  • 8 South America Anticancer Drug by Countries

    • 8.1 South America Anticancer Drug Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Anticancer Drug Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Anticancer Drug Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Anticancer Drug Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Anticancer Drug Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Anticancer Drug Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Anticancer Drug by Countries

    • 9.1 Middle East and Africa Anticancer Drug Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Anticancer Drug Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Anticancer Drug Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Anticancer Drug Sales and Growth Rate (2013-2018)
  • 9.3 UAE Anticancer Drug Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Anticancer Drug Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Anticancer Drug Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Anticancer Drug Sales and Growth Rate (2013-2018)
  • 10 Global Anticancer Drug Market Segment by Type

    • 10.1 Global Anticancer Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Anticancer Drug Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Anticancer Drug Revenue and Market Share by Type (2013-2018)
  • 10.2 Targeted Drugs Sales Growth and Price
  • 10.2.1 Global Targeted Drugs Sales Growth (2013-2018)
  • 10.2.2 Global Targeted Drugs Price (2013-2018)
  • 10.3 Cytotoxic Drugs Sales Growth and Price
  • 10.3.1 Global Cytotoxic Drugs Sales Growth (2013-2018)
  • 10.3.2 Global Cytotoxic Drugs Price (2013-2018)
  • 10.4 Hormonal Drugs Sales Growth and Price
  • 10.4.1 Global Hormonal Drugs Sales Growth (2013-2018)
  • 10.4.2 Global Hormonal Drugs Price (2013-2018)
  • 11 Global Anticancer Drug Market Segment by Application

    • 11.1 Global Anticancer Drug Sales Market Share by Application (2013-2018)
    • 11.2 Immunotherapy Sales Growth (2013-2018)
    • 11.3 Targeted Therapy Sales Growth (2013-2018)
    • 11.4 Chemotherapy Sales Growth (2013-2018)
    • 11.5 Hormonal Therapy Sales Growth (2013-2018)
    • 11.6 Others Sales Growth (2013-2018)

    12 Anticancer Drug Market Forecast (2018-2023)

    • 12.1 Global Anticancer Drug Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Anticancer Drug Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Anticancer Drug Market Forecast (2018-2023)
  • 12.2.2 Europe Anticancer Drug Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Anticancer Drug Market Forecast (2018-2023)
  • 12.2.4 South America Anticancer Drug Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Anticancer Drug Market Forecast (2018-2023)
  • 12.3 Anticancer Drug Market Forecast by Type (2018-2023)
  • 12.3.1 Global Anticancer Drug Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Anticancer Drug Market Share Forecast by Type (2018-2023)
  • 12.4 Anticancer Drug Market Forecast by Application (2018-2023)
  • 12.4.1 Global Anticancer Drug Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Anticancer Drug Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

      Scope of the Report:

      Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.

      The worldwide market for Anticancer Drug is expected to grow at a CAGR of roughly 6.3% over the next five years, will reach 141800 million US$ in 2023, from 98300 million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Anticancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Roche

      Celgene

      Pfizer

      Bristol-Myers Squibb

      Novartis

      AstraZeneca

      Teva Pharmaceuticals

      Bayer

      GlaxoSmithKline

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Targeted Drugs

      Cytotoxic Drugs

      Hormonal Drugs

      Market Segment by Applications, can be divided into

      Immunotherapy

      Targeted Therapy

      Chemotherapy

      Hormonal Therapy

      Others

      There are 15 Chapters to deeply display the global Anticancer Drug market.

      Chapter 1, to describe Anticancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Anticancer Drug, with sales, revenue, and price of Anticancer Drug, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Anticancer Drug, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Anticancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Anticancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


      Summary:
      Get latest Market Research Reports on Anticancer Drug . Industry analysis & Market Report on Anticancer Drug is a syndicated market report, published as Global Anticancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Anticancer Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report